Bristol Myers Squibb Gets New Nvidia AI Power
Bristol Myers Squibb is the first medical company to buy an Nvidia DGX SuperPOD using the new Vera Rubin architecture. This high speed computer system is designed to handle complex data at a massive scale.
The company will use this hardware to improve their drug discovery process. By processing data faster, researchers hope to identify promising treatments much earlier than before.
Nvidia recently launched this architecture to help companies solve difficult scientific problems. This partnership shows how big drug makers are investing heavily in new technology to change how they build medicine.
Comments (0)
No comments yet. Be the first!
More AI news
NewsMicrosoft and Mistral Team Up for European AI
Microsoft is investing billions to help Mistral build new AI technology throughout Europe.
NewsWhy AI Feels Like a Slot Machine
Using AI tools can trap you in a cycle of endless tweaks that kills your productivity.
NewsAlibaba's New Voice Model Takes Top Spot
Alibaba released a new text to speech model that currently ranks first on the industry leaderboard.